Babar Ali, MD
Interventional Cardiology · Takoma Park, MDNPI 1952505877
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.6% of the total across 265 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 17.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,240 and has fallen 50.3% since, to $1,114 in 2025.
Across 265 payments — averaging $34.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Philips North America LLC$2K
- Cook Medical LLC$1K
- Medtronic$848
- Surmodics, Inc.$784
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$620
- Boston Scientific$473
- plus $4K from 30 others
What the payments were for
- Travel & lodging$2883%
- Food & beverage$8,70796%
- Education$1151%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Philips North America LLC | 25 | $1,565 |
| Cook Medical LLC | 36 | $1,191 |
| Medtronic(2 entities) | 15 | $848 |
| Surmodics, Inc. | 10 | $784 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 19 | $620 |
| Boston Scientific | 11 | $473 |
| Amgen | 22 | $431 |
| Abbott | 5 | $386 |
| Novartis | 23 | $371 |
| Terumo Medical Corporation | 5 | $287 |
| AstraZeneca | 9 | $272 |
| Pfizer | 12 | $222 |
| E.r. Squibb & Sons, L.L.C. | 11 | $198 |
| Johnson & Johnson | 10 | $192 |
| W. L. Gore & Associates, Inc. | 6 | $127 |
| Alnylam Pharmaceuticals Inc. | 5 | $120 |
| Dexcom, Inc. | 1 | $120 |
| Actelion Pharmaceuticals US, Inc. | 1 | $95 |
| Bayer | 4 | $76 |
| Merck | 3 | $72 |
| Amarin Pharma, Inc. | 4 | $70 |
| Silk Road Medical, Inc. | 3 | $63 |
| Atricure, Inc. | 2 | $59 |
| Baxter Healthcare | 1 | $59 |
| Sanofi-aventis U.S. LLC | 3 | $52 |
| Biotronik Inc. | 2 | $52 |
| Penumbra, Inc. | 1 | $46 |
| Astellas Pharma US Inc | 2 | $39 |
| Shockwave Medical, Inc | 2 | $38 |
| Boehringer Ingelheim | 2 | $33 |
| Cardiovascular Systems Inc. | 2 | $32 |
| Regeneron Healthcare Solutions, Inc. | 2 | $31 |
| Arbor Pharmaceuticals, Inc. | 2 | $30 |
| Kowa Pharmaceuticals America, Inc. | 2 | $25 |
| Edwards Lifesciences | 1 | $17 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Sublime 014 Rx PTA Balloon Dilatation Catheter$1,097
- Sublime Radial Access 018 RX PTA Dilatation Catheter$549
- Sublime Microcatheter, 014, 65cm, Straight$549
- Sublime Microcatheter, 014, 65cm, Angle$549
- (4066) Tack Endo Sys ATK$278
- Diamondback Peripheral$200
- AVVIGO Guidance System$193
- Resolute$190
- (4067) Tack Endo Sys BTK$163
- Abre$157
- R2P MISAGO$140
- Navicross$140
- METACROSS OTW$140
- Micra$137
- (6554) Peripheral Vascular Undivided$128
- DEXCOM G6 TRANSMITTER$120
- Trilogy 100$119
- ADVANCE$116
- BRILINTA$113
- Confirm Rx$112
How this compares
$9,110 in reported general payments places this provider in the 55th percentile of 71 interventional cardiology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 32 | $31,406 |
| EliquisApixaban | 47 | $31,169 |
| BrilintaTicagrelor | 27 | $15,032 |
| EntrestoSacubitril/Valsartan | 11 | $8,617 |
| Metoprolol Succinate | 116 | $1,989 |
| Nebivolol Hcl | 22 | $1,495 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 14 | $786 |
| Lisinopril | 104 | $599 |
| Losartan Potassium | 90 | $579 |
| Amlodipine Besylate | 133 | $565 |
| Atorvastatin Calcium | 58 | $550 |
| Rosuvastatin Calcium | 47 | $501 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 29 | $429 |
| ClopidogrelClopidogrel Bisulfate | 37 | $407 |
| Carvedilol | 26 | $192 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $192 | $31,40632 claims |
| PfizerEliquis | $222 | $31,16947 claims |
| AstraZenecaBrilinta | $272 | $15,03227 claims |
| NovartisEntresto | $371 | $8,61711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 71 interventional cardiology providers in Maryland.
Other interventional cardiology in Takoma Park
- Vinay SatwahGreenbelt$679K
- Aloke FinnBaltimore$575K
- Michael ChenRockville$241K
- John WangBaltimore$138K
- Steven HearneSalisbury$100K
- Amir NajafiBel Air$82K
- Diljon ChahalBaltimore$78K
- Joseph CinderellaSalisbury$72K
- Ali TabrizchiBel Air$66K
- Homam IbrahimSilver Spring$49K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.